Knygos.lt nariams
Knygos.lt nariams
- Išsiųsime per 12–18 d.d.
/images/books/11288019/9781588294852.jpg)
- Leidėjas: Humana Press
- Metai: 2005
- Puslapiai: 306
- ISBN-10: 1588294854
- ISBN-13: 9781588294852
- Formatas: 17.7 x 23.7 x 2.7 cm, kieti viršeliai
- Kalba: Anglų
Myeloid Leukemia (el. knyga) (skaityta knyga) | knygos.lt
Atsiliepimai
Aprašymas
A panel of internationally recognized research scientists and clinical investigators brings together a diverse collection of readily reproducible methods for identifying and quantifying a large number of specific genetic abnormalities associated with the broad spectrum of myeloid malignancies. Highlights include techniques for the detection of BCR-ABL mutations and resistance to imatinib mesylate, detection of the FIP1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia, classification of AML by DNA-oligonucleotide microarrays, and detection of the V617F JAK2 mutation in myeloproliferative disorders. In addition to gene rearrangments, other prognostically relevant molecular lesions such as FLT3 mutations and WT-1 overexpression are covered.
- Leidėjas: Humana Press
- Metai: 2005
- Puslapiai: 306
- ISBN-10: 1588294854
- ISBN-13: 9781588294852
- Formatas: 17.7 x 23.7 x 2.7 cm, kieti viršeliai
- Kalba: Anglų
A panel of internationally recognized research scientists and clinical investigators brings together a diverse collection of readily reproducible methods for identifying and quantifying a large number of specific genetic abnormalities associated with the broad spectrum of myeloid malignancies. Highlights include techniques for the detection of BCR-ABL mutations and resistance to imatinib mesylate, detection of the FIP1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia, classification of AML by DNA-oligonucleotide microarrays, and detection of the V617F JAK2 mutation in myeloproliferative disorders. In addition to gene rearrangments, other prognostically relevant molecular lesions such as FLT3 mutations and WT-1 overexpression are covered.
Atsiliepimai